Leuprolide Acetate: Clinical Trials

68 trials of Leuprolide Acetate, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

34 completed, 10 active not recruiting, 9 terminated, 5 recruiting. 68 Phase 2, 5 Phase 1, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 268Completed 34, Active not recruiting 10, Terminated 9, Recruiting 5, Unknown 5, Withdrawn 5
Phase 15Completed 3, Terminated 2
Phase 32Active not recruiting 1, Unknown 1

Follow Leuprolide Acetate: new trials by email Literature Review of Leuprolide Acetate trials Research Report on Leuprolide Acetate

Trials (filtered) newest first · largest first

All 68 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of PSMA-targeted Therapy and Androgen Receptor Suppression in Low-volume Metastatic ProstatE Cancer: SPARKLE Trial
Abiraterone Acetate, Biospecimen Collection, Leuprolide Acetate - Recurrent Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC v8
Phase 2RecruitingMayo Clinic2022026-08-042026-09-18
Adjuvant Rezvilutamide in Combination With Androgen Deprivation Therapy in Androgen Receptor-positive, High-risk Salivary Duct Carcinoma
Rezvilutamide, Leuprolide Acetate - Salivary Gland Neoplasm Duct
Phase 2RecruitingPeking University First Hospital372024-10-102025-09-23
Study to Test the Drug Darolutamide Along With the Drugs Leuprolide Acetate and Exemestane in Patients With Recurrent Ovarian Granulosa Cell Tumors
Biospecimen Collection, Chest Radiography, Computed Tomography - Adult Ovarian Granulosa Cell Tumor
Phase 2CompletedNational Cancer Institute (NCI)172024-02-082026-11-03
A Neoadjuvant Study of Abiraterone Acetate, Leuprolide Acetate, and Belzutifan in Men With Regional Prostate Cancer
Neoadjuvant treatment - Prostate Cancer
Phase 2WithdrawnSidney Kimmel Comprehensive Cancer Center at Johns Hopkins2024-01-012024-03-18
Testing the Anti-cancer Drug Darolutamide in Patients With Testosterone-Driven Salivary Gland Cancers
Biopsy Procedure, Biospecimen Collection, Computed Tomography - Locally Advanced Salivary Gland Carcinoma, Metastatic Salivary Gland Carcinoma
Phase 2Active not recruitingNational Cancer Institute (NCI)202023-07-202026-11-16
Kisspeptin Administration Subcutaneously to Patients With IHH
kisspeptin 112-121, leuprolide acetate - Hypogonadotropic Hypogonadism
Phase 2RecruitingStephanie B. Seminara, MD362023-02-032026-07-13
RElugolix VErsus LeUprolide Cardiac Trial
Radiation therapy, Leuprolide, Relugolix - Biochemically Recurrent Prostate Carcinoma, Localized Prostate Carcinoma
Phase 2Active not recruitingEmory University942022-06-062026-02-12
Enhanced Systemic Combined With Local Treatment for Primary and Metastatic Lesions in Oligo-metastatic Prostate Cancer
Leuprolide acetate, Goserelin acetate, Triptorelin acetate - Prostate Cancer
Phase 2UnknownFudan University1602022-04-012022-03-16
Talazoparib With Androgen Deprivation Therapy and Abiraterone for the Treatment of Castration Sensitive Prostate Cancer
Abiraterone Acetate, Bicalutamide, Degarelix - Castration-Sensitive Prostate Carcinoma, Metastatic Prostate Adenocarcinoma
Phase 2RecruitingCity of Hope Medical Center702021-05-042026-01-28
Antiandrogen Therapy and SBRT in Treating Patients With Recurrent, Metastatic Prostate Cancer
Abiraterone Acetate, Apalutamide, Leuprolide Acetate - Metastatic Prostate Adenocarcinoma, Prostate Adenocarcinoma With Focal Neuroendocrine Differentiation
Phase 2Active not recruitingJonsson Comprehensive Cancer Center282021-03-172026-02-05
Androgen Deprivation Therapy and Apalutamide With or Without Radiation Therapy for the Treatment of Biochemically Recurrent Prostate Cancer, RESTART Study
Apalutamide, Degarelix, Leuprolide Acetate - Biochemically Recurrent Prostate Carcinoma, Metastatic Prostate Carcinoma
Phase 2WithdrawnM.D. Anderson Cancer Center2020-11-242021-01-20
Neurobiology of Bulimia Nervosa
Estradiol, Micronized progesterone, Leuprolide Acetate - Bulimia Nervosa
Phase 2CompletedUniversity of North Carolina, Chapel Hill102020-02-242022-07-26
REGN2810 Followed by Chemoimmunotherapy for Newly Metastatic Hormone-sensitive Prostate Cancer
REGN2810, Degarelix, Leuprolide Acetate - Prostate Cancer Metastatic
Phase 2Active not recruitingMark Stein262019-05-162025-04-25
A Study of Salvage Radiotherapy With or Without Enzalutamide in Recurrent Prostate Cancer Following Surgery
Radiation Therapy, Enzalutamide, Bicalutamide - Prostate Cancer
Phase 2Active not recruitingRTOG Foundation, Inc.1882019-04-152025-12-30
Radium Ra 223 Dichloride, Hormone Therapy and Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Prostate Cancer
Leuprolide Acetate, Goserelin Acetate, Stereotactic Body Radiation Therapy - Prostate Adenocarcinoma
Phase 2Active not recruitingCity of Hope Medical Center252018-08-292026-04-09
Phase II High Risk Prostate Cancer Trial Using Gene & Androgen Deprivation Therapies, Radiotherapy, & Surgery
HSV-Tk, Valacyclovir, Bicalutamide - High-risk Prostate Cancer, Prostate Cancer
Phase 2RecruitingThe Methodist Hospital Research Institute602018-08-022021-04-06
A Study of Docetaxel + ARN-509 in Castration-Resistant Prostate Cancer
Leuprolide Acetate, Prednisone, Docetaxel - Prostate Cancer
Phase 2TerminatedDana-Farber Cancer Institute92017-06-232020-04-09
Pembrolizumab +/- SD-101 in Hormone-Naïve Oligometastatic Prostate Cancer With RT and iADT
Pembrolizumab, SD-101, Leuprolide acetate - Prostatic Neoplasms
Phase 2CompletedDavid Oh232017-05-172025-12-05
A Study of Definitive Therapy to Treat Prostate Cancer After Prostatectomy
Leuprolide Acetate, Docetaxel, Bicalutamide - Prostate Cancer
Phase 2CompletedSidney Kimmel Comprehensive Cancer Center at Johns Hopkins262017-02-222023-02-16
A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study
enzalutamide, abiraterone acetate, prednisone - Prostate Cancer
Phase 2Active not recruitingAstellas Pharma Global Development, Inc.9002016-12-222026-10-13

Showing 20 of 68. Sign in to see all of them.

Conditions studied

Prostatic Neoplasms (48)  ·  Breast Neoplasms (3)  ·  Alzheimer Disease (2)  ·  Neoplasms (2)  ·  Acanthosis Nigricans (1)  ·  Adenocarcinoma (1)  ·  Amenorrhea (1)  ·  Bulimia (1)  ·  Bulimia Nervosa (1)  ·  Carcinoma (1)  ·  Depression, Postpartum (1)  ·  Endocrine System Diseases (1)  ·  Feeding and Eating Disorders (1)  ·  Genital Neoplasms, Male (1)  ·  Granulosa cell tumor of the ovary (1)

Sponsors

M.D. Anderson Cancer Center (7)  ·  National Cancer Institute (NCI) (6)  ·  Mayo Clinic (5)  ·  City of Hope Medical Center (3)  ·  Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (3)  ·  University of Washington (3)  ·  Dana-Farber Cancer Institute (2)  ·  Fudan University (2)  ·  Voyager Pharmaceutical Corporation (2)  ·  Alliance for Clinical Trials in Oncology (1)  ·  Astellas Pharma Global Development, Inc. (1)  ·  Barbara Ann Karmanos Cancer Institute (1)  ·  Beth Israel Medical Center (1)  ·  Burzynski Research Institute (1)  ·  Camurus AB (1)

Countries

United States (57)  ·  Canada (4)  ·  China (4)  ·  Czechia (2)  ·  Finland (2)  ·  South Korea (2)  ·  Argentina (1)  ·  Australia (1)  ·  Austria (1)  ·  Belgium (1)  ·  Brazil (1)  ·  Chile (1)  ·  Denmark (1)  ·  France (1)  ·  Georgia (1)

Top investigators

Christopher Logothetis (2)  ·  Kenneth Pienta, MD (2)  ·  Richard L. Bowen, MD (2)  ·  Alan L Ho (1)  ·  Amar Kishan (1)  ·  Ana M. Aparicio, MD (1)  ·  Angela Smith, M.D. (1)  ·  Anthony V. D'Amico, MD, PhD (1)  ·  Celestia Higano, MD (1)  ·  Charles G. Drake, MD, PhD (1)  ·  Cy A Stein (1)  ·  David C. Smith, MD (1)  ·  David Oh, MD, PhD (1)

Results publications

PMID 17194907, PMID 18037582, PMID 18291508, PMID 20818327, PMID 22006050, PMID 22282904, PMID 25242417, PMID 25847934, PMID 30811282, PMID 31668850, PMID 33496795, PMID 35780048, PMID 37922910, PMID 38421243, PMID 38494380, PMID 39074346, PMID 39978378, PMID 40907514, PMID 41706486, PMID 42070324, PMID 42574969

NIH funding

P30CA015083 (4), P30CA033572 (2), U10CA032102 (2), 2016 (1), 2023 (1), N01CM00039 (1), N01CM62201 (1), N01CM62202 (1), N01CM62205 (1), N01CM62206 (1), P30CA008748 (1), P30CA015704 (1), P30CA016672 (1), P30CA022453 (1), P30CA138292 (1)